Innovative Regenerative Therapies Elevian is focused on developing medicines that promote body regeneration, targeting aging-related diseases and stroke recovery, which presents opportunities for partnerships with healthcare providers and clinics seeking advanced regenerative solutions.
Funding and Growth Potential With recent Series A funding of $40 million and pioneering programs in regenerative medicine, Elevian is positioned for expansion and collaboration with clinical research organizations and biotech investors focused on aging and neurological disorders.
Academic Industry Partnerships The company's partnership with Harvard indicates strong academic collaboration, opening avenues for joint research projects, grants, and academic healthcare institutions interested in cutting-edge regenerative treatments.
Technology and Manufacturing Readiness Elevian's hiring of a head of protein manufacturing and state-of-the-art tech stack suggest readiness for scaling production, creating opportunities to connect with biotech manufacturing firms and suppliers aiming to support early-stage clinical trials.
Market Position and Competition As a niche biotech with a focus on age-related diseases and regenerative medicine, Elevian's competitive landscape includes firms like Passage Bio and Calico, representing potential partnership or customer targets for innovative therapeutic development.
$25M$50M
$100M$250M
$1M$10M
$10M$25M
$10M$25M
$1M$10M
$1M$10M
$1M$10MElevian, Inc. uses 8 technology products and services including Tumblr, Open Graph, Webpack, and more. Explore Elevian, Inc.'s tech stack below.
| Elevian, Inc. Email Formats | Percentage |
| First.Last@elevian.com | 37% |
| First@elevian.com | 22% |
| Middle@elevian.com | 4% |
| First.Last@elevian.com | 37% |
Biotechnology ResearchUnited States11-50 Employees
At Elevian, we are developing new medicines that promote recovery and regeneration. Our lead program is a recombinant protein for the treatment of stroke in the days following the event, for which there are currently no viable treatments. By promoting regeneration, Elevian’s medicines have the potential to treat and prevent many aging-associated diseases.
Company Overview
Media & News
Funding & FinancialsElevian, Inc. has raised a total of $40M of funding over 5 rounds. Their latest funding round was raised on Sep 16, 2021 in the amount of $40M.
Elevian, Inc.'s revenue is estimated to be in the range of $10M$25M
Funding & FinancialsElevian, Inc. has raised a total of $40M of funding over 5 rounds. Their latest funding round was raised on Sep 16, 2021 in the amount of $40M.
Elevian, Inc.'s revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com